• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

WEI Feifei  魏 菲菲

… Alternative Names

魏 菲菲  ウェイ フェイフェイ

Less
Researcher Number 50833969
Other IDs
  • ORCIDhttps://orcid.org/0000-0002-5770-3255
Affiliation (Current) 2025: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), 臨床研究所がん免疫療法研究開発学部, 研究員
Affiliation (based on the past Project Information) *help 2025: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), 臨床研究所がん免疫療法研究開発学部, 研究員
2022 – 2023: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), 臨床研究所がん免疫療法研究開発学部, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 55010:General surgery and pediatric surgery-related
Keywords
Principal Investigator
機械学習 / がん免疫療法 / 低侵襲 / 末梢血可溶性因子 / 層別化 / biomarker / machine learning / cytokine / ICI
  • Research Projects

    (2 results)
  • Research Products

    (11 results)
  • Co-Researchers

    (2 People)
  •  AI駆動型末梢血分子シミュラントによるがん免疫治療応答性評価プラットフォームの開発Principal Investigator

    • Principal Investigator
      魏 菲菲
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kanagawa Cancer Center Research Institute
  •  Establishment of an AI-based platform for predicting response to cancer immunotherapyPrincipal Investigator

    • Principal Investigator
      魏 菲菲
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55010:General surgery and pediatric surgery-related
    • Research Institution
      Kanagawa Cancer Center Research Institute

All 2024 2023 2022

All Journal Article Presentation

  • [Journal Article] Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation2024

    • Author(s)
      Wei F, Kouro T, Nakamura Y, Ueda H, Iiizumi S, Hasegawa K, Asahina Y, Kishida T, Morinaga S, Himuro H, Horaguchi S, Tsuji K, Mano Y, Nakamura N, Kawamura T, Sasada T.
    • Journal Title

      Comput Struct Biotechnol J

      Volume: 23 Pages: 859-869

    • DOI

      10.1016/j.csbj.2024.01.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K18346, KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
  • [Journal Article] Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors2024

    • Author(s)
      Nakahara Yoshiro、Kouro Taku、Motoyama Satoru、Miura Masatomo、Fujita Kazuma、Igarashi Yuka、Higashijima Naoko、Matsuo Norikazu、Himuro Hidetomo、Wei Feifei、Horaguchi Shun、Tsuji Kayoko、Mano Yasunobu、Komahashi Mitsuru、Saito Haruhiro、Azuma Koichi、Sasada Tetsuro
    • Journal Title

      Frontiers in Cell and Developmental Biology

      Volume: -

    • DOI

      10.3389/fcell.2023.1324898

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-23H05274
  • [Journal Article] Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence2024

    • Author(s)
      Qin XY, Shirakami Y, Honda M, Yeh SH, Numata K, Lai YY, Li CL, Wei F, Xu Y, Imai K, Takai K, Chuma M, Komatsu N, Furutani Y, Gailhouste L, Aikata H, Chayama K, Enomoto M, Tateishi R, Kawaguchi K, Yamashita T, Kaneko S, Nagaoka K, Tanaka M, Sasaki Y, Tanaka Y, Baba H, Miura K, Ochi S, Masaki T, et al
    • Journal Title

      International Journal of Cancer

      Volume: - Issue: 3 Pages: 582-594

    • DOI

      10.1002/ijc.34893

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K08342, KAKENHI-PROJECT-21K07892, KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-20K07349, KAKENHI-PROJECT-21K07904, KAKENHI-PROJECT-21K07940
  • [Journal Article] MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors2024

    • Author(s)
      Nagasaka Hirotaka、Kishida Takeshi、Kouro Taku、Igarashi Yuka、Takebe Shinichi、Yamamoto Shotaro、Kondo Takuya、Koizumi Mitsuyuki、Terao Hideyuki、Suzuki Takahisa、Nakaigawa Noboru、Himuro Hidetomo、Wei Feifei、Sasada Tetsuro
    • Journal Title

      International Journal of Clinical Oncology

      Volume: - Issue: 6 Pages: 832-839

    • DOI

      10.1007/s10147-024-02477-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-19K09676, KAKENHI-PROJECT-21H02995
  • [Journal Article] Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma2023

    • Author(s)
      Shibata Yosuke、Kishida Takeshi、Kouro Taku、Wei Feifei、Igarashi Yuka、Himuro Hidetomo、Noguchi Takeaki、Koizumi Mitsuyuki、Suzuki Takahisa、Osaka Kimito、Saigusa Yusuke、Sasada Tetsuro
    • Journal Title

      Frontiers in Pharmacology

      Volume: 14 Pages: 1269935-1269935

    • DOI

      10.3389/fphar.2023.1269935

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
  • [Journal Article] Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer2023

    • Author(s)
      Wei Feifei、Sasada Tetsuro
    • Journal Title

      Genes & Immunity

      Volume: 25 Issue: 1 Pages: 89-91

    • DOI

      10.1038/s41435-023-00236-5

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
  • [Journal Article] Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures2023

    • Author(s)
      Wei Feifei、Azuma Koichi、Nakahara Yoshiro、Saito Haruhiro、Matsuo Norikazu、Tagami Tomoyuki、Kouro Taku、Igarashi Yuka、Tokito Takaaki、Kato Terufumi、Kondo Tetsuro、Murakami Shuji、Usui Ryo、Himuro Hidetomo、Horaguchi Shun、Tsuji Kayoko、Murotani Kenta、Ban Tatsuma、Tamura Tomohiko、Miyagi Yohei、Sasada Tetsuro
    • Journal Title

      Journal for ImmunoTherapy of Cancer

      Volume: 11 Issue: 7 Pages: e006788-e006788

    • DOI

      10.1136/jitc-2023-006788

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02954, KAKENHI-PROJECT-21H02995
  • [Journal Article] Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.2023

    • Author(s)
      Hidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Feifei Wei, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Haruhiro Saito, Koichi Azuma, Tetsuro Sasada
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: na Issue: 8 Pages: 2829-2840

    • DOI

      10.1007/s00262-023-03464-w

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
  • [Journal Article] 腫瘍細胞からネットワークへ-遺伝子変異とサイトカインネットワークによる腫瘍微小環境の形成と制御2022

    • Author(s)
      魏菲菲、笹田哲朗
    • Journal Title

      医学のあゆみ

      Volume: 281 Pages: 374-380

    • Data Source
      KAKENHI-PROJECT-22K08724
  • [Presentation] HLA-Mascot: Machine Learning-based False Positive Filter in Tumor Immunopeptidomics by Mass Spectrometry2023

    • Author(s)
      魏菲菲,紅露拓,中村有子,上田宏生,氷室秀知,洞口俊, 辻嘉代子,眞野恭伸,中村徳弘,川村猛,笹田哲朗
    • Organizer
      第82回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-22K08724
  • [Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022

    • Author(s)
      魏菲菲、東公一、中原善朗、齋藤春洋、紅露拓、氷室秀知、洞口俊、辻嘉代子、笹田哲朗
    • Organizer
      第81回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-22K08724
  • 1.  笹田 哲朗 (70293967)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 10 results
  • 2.  MASAKI Takahiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi